Cargando…

Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs

Detalles Bibliográficos
Autor principal:	Georgiev, Tsvetoslav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103900/ https://www.ncbi.nlm.nih.gov/pubmed/32232552 http://dx.doi.org/10.1007/s00296-020-04570-z

Ejemplares similares

Management of pediatric rheumatic patients in Kazakhstan during the coronavirus disease 2019 (COVID-19) pandemic
por: Mukusheva, Zaure, et al.
Publicado: (2020)

COVID-19, rheumatic diseases and immunosuppressive drugs: an appeal for medication adherence
por: Venerito, Vincenzo, et al.
Publicado: (2020)

Prevalence of coronavirus disease 2019 in rheumatic patients and evaluation of the effect of disease-modifying anti-rheumatic drugs
por: Moradi, Soroush, et al.
Publicado: (2020)

The impact of anti-epidemic measures against coronavirus disease 2019 (COVID-19) on the seasonal influenza epidemic
por: Ilyicheva, Tatyana N., et al.
Publicado: (2021)

Myasthenic crisis in the setting of Coronavirus Disease 2019 (COVID-19)
por: Salik, Irim, et al.
Publicado: (2020)

The many faces of coronavirus disease 2019: COVID-19 and the liver
por: Almas, Talal, et al.
Publicado: (2021)

SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis
por: Velikova, Tsvetelina, et al.
Publicado: (2021)

Incident systemic rheumatic disease following COVID-19
por: Hsu, Tiffany Y-T, et al.
Publicado: (2021)

Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19)
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Cyclosporine therapy in cytokine storm due to coronavirus disease 2019 (COVID-19)
por: Cure, Erkan, et al.
Publicado: (2020)

Coronavirus disease 2019 (COVID‐19) vaccination in patients with cirrhosis: Does it work?
por: Calleri, Alberto, et al.
Publicado: (2022)

Complexities of diagnosis and management of COVID-19 in autoimmune diseases: Potential benefits and detriments of immunosuppression
por: Georgiev, Tsvetoslav, et al.
Publicado: (2020)

Famotidine and Coronavirus Disease 2019
por: Freedberg, Daniel E., et al.
Publicado: (2021)

Coronavirus disease 2019 (COVID-19) during pregnancy in patients with rheumatic diseases
por: Boyadzhieva, Vladimira Vasileva, et al.
Publicado: (2020)

The risk of coronavirus disease 2019 (COVID-19) among individuals with monoclonal B cell lymphocytosis
por: Parikh, Sameer A., et al.
Publicado: (2022)

Famotidine and Mortality in Coronavirus Disease 2019
por: Sethia, Rahul, et al.
Publicado: (2021)

Asthma and prognosis of coronavirus disease 2019
por: Özdemir, Öner
Publicado: (2022)

Left Ventricular Systolic Function and Inpatient Mortality in Patients Hospitalized with Coronavirus Disease 2019 (COVID-19)
por: Faridi, Kamil F., et al.
Publicado: (2020)

Hospitalized coronavirus disease-2019 (COVID-19) patients with gastrointestinal symptoms have improved survival to discharge
por: Renelus, Benjamin D., et al.
Publicado: (2020)

Effects of coronavirus disease 2019 (COVID-19), including its prevention and treatment, on the male reproductive system
por: Liu, Kai, et al.
Publicado: (2021)

Rheumatic disease management in the Campania region of Italy during the COVID-19 pandemic
por: Masini, Francesco, et al.
Publicado: (2020)

Self-care recommendations for patients with rheumatic diseases during the COVID-19 pandemic
por: Kim, Hyun-Sook, et al.
Publicado: (2020)

Split-dosing of coronavirus disease 2019 vaccines
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

MicroCLOTS pathophysiology in coronavirus disease 2019
por: Renzi, Samuele, et al.
Publicado: (2023)

Novel coronavirus disease-2019 (COVID-19) in people with rheumatic disease: Epidemiology and outcomes
por: Grainger, Rebecca, et al.
Publicado: (2021)

Case-fatality with coronavirus disease 2019 (COVID-19) in United States Veterans with spinal cord injuries and disorders
por: Burns, Stephen P., et al.
Publicado: (2020)

Clinical characteristics of 1327 patients with coronavirus disease 2019 (COVID-19) in the largest Fangcang shelter hospital in Wuhan
por: Lu, Chong, et al.
Publicado: (2021)

COVID-19 and Disease-Modifying Anti-rheumatic Drugs
por: D’Silva, Kristin M., et al.
Publicado: (2021)

Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians
por: Schreiber, Karen, et al.
Publicado: (2020)

Safety and efficacy of COVID-19 vaccines in pregnant women with rheumatic diseases: an immunologic perspective
por: Tariq, Javeria, et al.
Publicado: (2021)

Coronavirus disease 2019 presenting with conjunctivitis as the first symptom
por: Casalino, Giuseppe, et al.
Publicado: (2020)

Etoposide for Cytokine Storm Because of Coronavirus Disease 2019
por: Delgado-López, Pedro David, et al.
Publicado: (2021)

Management Issues of Sarcoidosis in the Time of Coronavirus Disease 2019
por: Tana, Claudio, et al.
Publicado: (2021)

Zinc and Coronavirus Disease 2019: Causal or Casual Association?
por: Khurana, Alkesh Kumar, et al.
Publicado: (2021)

Exacerbation of livedoid vasculopathy after Coronavirus disease 2019
por: Kawabe, Ryoko, et al.
Publicado: (2022)

Inverse Association Between Chronic Hepatitis B Infection and Coronavirus Disease 2019 (COVID-19): Immune Exhaustion or Coincidence?
por: Anugwom, Chimaobi M, et al.
Publicado: (2020)

Bacillus Calmette-Guerin (BCG) Site Reaction after Coronavirus Disease 2019 (COVID-19) mRNA Vaccination
por: Günaydın, Sibel Doğan, et al.
Publicado: (2023)

Prevalence of Rheumatic Heart Disease
por: Ceylan, Özben, et al.
Publicado: (2017)

Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease
por: Kow, Chia Siang, et al.
Publicado: (2020)

Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection
por: Hariyanto, Timotius Ivan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_huj77tedosjsn2pq3fis1btatt